Advances in the development of new tuberculosis drugs and treatment regimens
作者： Alimuddin Zumla , Payam Nahid , Stewart T. Cole
DOI: 10.1038/NRD4001
关键词: Drug resistance 、 Isoniazid 、 Immunology 、 Clinical trial 、 Rifampicin 、 Moxifloxacin 、 Pyrazinamide 、 Tuberculosis 、 Medicine 、 Intensive care medicine 、 Ethambutol
摘要: … , new and novel drugs and regimens for all forms of TB are emerging. Such regimens are likely to utilize both repurposed drugs and new … drug discovery and development, including an …
nature.com
sci-hub.se 参考文章(127)
Albert Schatz, Elizabeth Bugie, Selman A Waksman, Arlen D Hanssen, Robin Patel, Douglas R Osmon, Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. 1944. Clinical Orthopaedics and Related Research. pp. 3- 6 ,(2005) , 10.1097/01.BLO.0000175887.98112.FE
Tuberculosis Coalition for Technical Assistance, 邦彦 伊藤, Philip C Hopewell, 結核医療の国際基準 International standard for tuberculosis care (ISTC) [結核研究所], 2007. ,(2007)
Abigail Salyers, Kim Lewis, Harry Taber, Richard Wax, Bacterial Resistance to Antimicrobials ,(2001)
A Zumla, HS Schaaf, Tuberculosis: A Comprehensive Clinical Reference ,(2009)
C Kendall Stover, Paul Warrener, Donald R VanDevanter, David R Sherman, Taraq M Arain, Michael H Langhorne, Scott W Anderson, J Andrew Towell, Ying Yuan, David N McMurray, Barry N Kreiswirth, Clifton E Barry, William R Baker, None, A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature. ,vol. 405, pp. 962- 966 ,(2000) , 10.1038/35016103
Jotblad S, Hopewell Pc, Steingart Kr, Nahid P, Huang D, Robsky K, Deck D, Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review. International Journal of Tuberculosis and Lung Disease. ,vol. 15, pp. 305- 316 ,(2011)
Hyunchul Kim, Han-Seung Jeon, Ina Jeong, Joon Sung Joh, Ray Y. Chen, Kenneth N. Olivier, Pamela A. Shaw, Dean Follmann, Sun Dae Song, Jong-Koo Lee, Dukhyoung Lee, Cheon Tae Kim, Veronique Dartois, Seung-Kyu Park, Sang-Nae Cho, Clifton E. Barry, Myungsun Lee, Jongseok Lee, Matthew W. Carroll, Hongjo Choi, Seonyeong Min, Taeksun Song, Laura E. Via, Lisa C. Goldfeder, Eunhwa Kang, Boyoung Jin, Hyeeun Park, Hyunkyung Kwak, Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis The New England Journal of Medicine. ,vol. 367, pp. 1508- 1518 ,(2012) , 10.1056/NEJMOA1201964
Ruth J. Napier, Wasiulla Rafi, Mani Cheruvu, Kimberly R. Powell, M. Analise Zaunbrecher, William Bornmann, Padmini Salgame, Thomas M. Shinnick, Daniel Kalman, Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis Cell Host & Microbe. ,vol. 10, pp. 475- 485 ,(2011) , 10.1016/J.CHOM.2011.09.010
P. L. Lin, V. Dartois, P. J. Johnston, C. Janssen, L. Via, M. B. Goodwin, E. Klein, C. E. Barry, J. L. Flynn, Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques Proceedings of the National Academy of Sciences of the United States of America. ,vol. 109, pp. 14188- 14193 ,(2012) , 10.1073/PNAS.1121497109